. 2023 Feb 27;3:1043874. doi: 10.3389/fneph.2023.1043874
Copyright © 2023 Fenoglio, Cozzi, Del Vecchio, Sciascia, Barreca, Comandone and Roccatello
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
Figure 1.
Number (A) and classes (B) of cancer drugs that patients were taking at the time of the biopsy.